*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
The Financial Mail on Sunday's Midas column recommended that its readers but shares of Artisanal Spirits Co. , judging its lacklustre debut on the junior market to ne undeserved.
The Sunday Times's Sabah Meddings told readers to 'hold' shares of IP Group due to their valuation, even as she touted the many "gems" to be found in its portfolio.
The Financial Mail on Sunday's Midas column told readers to buy shares of Aviva, pointing out the recent share purchases by its chairman and the company's ongoing reorganisation which it said would pay dividends in the future.
The Sunday Times's Sabah Meddings thinks Volex's shares a buy, pointing to the recovery in all of the company's end markets recover and non-organic growth opportunities to back up her case.
The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.
The Financial Mail on Sunday's Midas column told readers to 'buy' shares of Crossword Cybersecurity, highlighting its roll in the development of Covid-19 certificates.
The Financial Mail on Sunday's Midas column called readers' attention to shares of Foresight Group, pointing out the company's long-track record in the renewable energy space, solid management and hence its long-term potential.
The Sunday Times's Sam Chambers advised readers to "avoid" shares of Dr Martens, cautioning of the potential long-term pitfalls of its current focus on profitability.
The Sunday Times's Sabah Meddings conceded that Softcat had done well out of the pandemic, but told readers the shares were only a 'hold' given their "punchy" valuation.
Deliveroo's debut on the stockmarket was a flop and investors now need to gauge just how much risk they are willing to take on, or hold onto if they took part in the share sale, said the Financial Mail on Sunday's Midas column.
The Financial Mail on Sunday's Midas column recommended shares of BBGI to its readers, calling attention to management's good track record and the firm's "rich" pipeline of potential investments.
The Financial Mail on Sunday's Midas column tipped stock in Supermarket Income REIT, telling readers the company, which owns a portfolio of large supermarkets across the country is set to benefit from Britons' changed attitudes even once the pandemic was in the rear-view mirror.
